It’s REF week on the Research Blog and I also have to give a talk to the BU Board on Thursday about progress with our REF preparations, but I am sitting here wondering what to write? Does this often happen to you? I often put these things off and turn my hand to something else, like the paper I am currently struggling to complete, or keeping up with my email correspondence rather than tackle the task in hand. But you see, here am I avoiding starting on the piece again, so I had better get started before it gets any later.
For the Board presentation I am taking a historical view of REF and its ancestors. It started out in 1985 as the Research Selectivity Exercise, before progressing in its third iteration to the Research Assessment Exercise (RAE) in 1992 which was the first time research funds (QR – Quality Research Income) was distributed as a consequence of the outcome. In some ways it was only in 1997 that universities had really got their act together and begun to take the RAE seriously, and by 2001 it was a major focus of energy in higher education and was beginning to result in a progressive concentration of research funding in a few key institutions. BU’s greatest success to date was in 2008 when we were the fourth most improved university in the country, and for the first time BU started to receive significant QR income as a result.
Apart from dominating the lives of many researchers, you may well ask what it has done for UK research. Well, the answer is actually a huge ton! In the 1970s, research in UK universities was funded via a government block grant and the UK was a middle-ranking research power, complacent, inefficient and underperforming. According to the recent BIS survey with the catchy title International Comparative Performance of the UK Research Base – 2011 the UK is now a leading research nation in the world, second only to the US. The much quoted headlines run something like: 1% of the world’s population, 3% of R&D spend, 4% of researchers, but 6% of articles, 10% of citations, 14% of the most cited articles. According to HEFCE, for every pound spent on research in the UK you get between four and seven pounds back. When seen in this context, the RAE has done its job extremely well by introducing competition into the sector. There are parallels here with the current move to introduce competition around student numbers.
Since RAE2008, goal posts have changed again as the name has changed to the Research Excellence Framework (REF) with the introduction of ‘Impact’ as an element of the assessment. In 2014, it will contribute 20% of the overall profile that a Unit of Assessment (UOA) will receive. At its simplest, impact is about justifying research spending from the public purse by demonstrating the societal benefit – economic, environmental, social, or cultural – from research. It is a great concept and speaks to the heart of societal relevance which we are placing at the centre of BU’s future research strategy. It will be assessed as part of REF via a series of case studies and each case study has to be based on a piece or body of research undertaken in the last 15 years, with an evidenced impact since 2008. The basic idea is that impact often takes time to come to fruition, but for a youthful institution like our own this is challenging since the research belongs to the university where it was done, not to the researcher. In the last 5 years there has been a steady influx of talented researchers to BU, but in many cases their impact belongs to another university! 
The need to evidence societal benefit is also important – it’s not enough just to have changed government policy for example; one needs to demonstrate the benefit of that change to ordinary people. The example we often use is that of seatbelts. Professor X does some research into seat belts and convinces government to legislate with respect to their introduction. This only counts, however, as interim impact – to complete the case study, one would have to demonstrate how that legislation has reduced road traffic accidents. So evidencing one’s claim is critical. I have used this example on several occasions but was somewhat challenged when an individual in the audience pointed out that this could also be construed in a negative way since seatbelts have reduced the number of organ donors! You will no doubt be able to guess at this point that I was talking to staff in HSC at the time.
The point is that it is all about the narrative you build from a piece of research and how you evidence that claim. There are some challenges for us around the issue of impact, but it also offers great opportunity. So I think it is time for me to finish here and go back to working on my Board presentation.



RASG – The REF Academic Steering Group (RASG) has been established as the primary decision-making body for the BU REF preparations. It first met on 14 June 2010 and normally meets on a monthly basis. The RASG Terms of Reference (including a list of members) can be accessed via the I-drive.
Welcome to the launch of our snazzy new look BU Research Blog, designed for us by the
There have been a number of large scale, cross-School and/or inter-university collaborative bids, internally led by members of the Professoriate, submitted this month which is excellent news. Good luck therefore to Edwin van Teijlingen and Anthea Innes in HSC for submitting two large collaborative proposals to the EC under the FP7 Health calls, to Alan Fyall, Feifei Xu (both ST) and Adrian Newton (ApSci) for submitting a cross-School and inter-university collaborative bid to ESPA. Good luck also to Oleg Fryazinov (MS) for a bid to the European Research Council, Vijay Reddy, John Fletcher and Richard Gordon (ST) for submitting a bid to the ESRC, Alan Fyall, Dimitrios Buhalis, Philip Alford and John Brackstone (ST) for a bid to the ESRC’s Knowledge Exchange call, Simon Thompson (DEC) for a large bid to the ESRC’s (Open Research Area in Europe) call, Phil MacGregor (MS) for a fellowship bid to the AHRC, and to Sarah Hean (HSC) for a bid to the ESRC.
Congratulations to Crispin Farbrother (ST) for a small consultancy contract with Dorset County Hospital, Richard Gordon (ST) for securing another training contract with the Foreign and Commonwealth Office, Jon Wardle (MS) for a production contract with Skillset, Mark Maltby (ApSci) for a small bones consultancy contract with Bedfordshire County Council, Roger Herbert (ApSci) for winning a contract with Shellfish Association of Great Britain, and to Gill Jordan (HSC) who has been awarded a large contract with the South West Strategic Health Authority.
Bibliometrics pilot – HEFCE ran a pilot exercise in the construction of bibliometric indicators of research quality in 2008-09, using 

The REF will assess research excellence through a process of expert review, informed by indicators where appropriate. It will be based on HEIs submitting evidence of their research activity and outcomes, to be assessed by expert panels.
The event opened with a fantastic presentation by
The second speaker was
The event then focused on BU’s experience of open access publishing with presentations from
What are bibliometrics?
Web of ScienceSM is hosted by Thomson Reuters and consists of various databases containing information gathered from thousands of scholarly journals, books, book series, reports, conference proceedings, and more:


Why do I need to think about the impact of my research?













ESRC Festival of Social Science 2026: An Opportunity to Engage New Audiences
New HIV paper by BU PhD student
BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease